Идёт
Фаза II–III
Zanubrutinib; Tacrolimus · BeOne Medicines
A Phase 2/3, Multicenter, Randomized, Active-Controlled, Open-label Study to Evaluate the Efficacy and Safety of Zanubrutinib in Patients With Primary Membranous Nephropathy